CME Group’s (CME) Buy Rating Reaffirmed at Deutsche Bank

CME Group (NASDAQ:CME)‘s stock had its “buy” rating reaffirmed by stock analysts at Deutsche Bank in a report issued on Thursday. They currently have a $192.00 price objective on the financial services provider’s stock, up from their previous price objective of $185.00. Deutsche Bank’s target price would indicate a potential upside of 8.78% from the stock’s current price.

Other research analysts have also recently issued reports about the company. Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a report on Tuesday, September 18th. Compass Point assumed coverage on CME Group in a report on Monday, July 9th. They set a “neutral” rating and a $170.00 target price on the stock. BidaskClub cut CME Group from a “buy” rating to a “hold” rating in a report on Tuesday, July 10th. Rosenblatt Securities assumed coverage on CME Group in a report on Wednesday, September 5th. They set a “neutral” rating and a $177.00 target price on the stock. Finally, Wells Fargo & Co boosted their target price on CME Group from $170.00 to $175.00 and gave the stock a “market perform” rating in a report on Monday, July 9th. Five equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $178.93.

NASDAQ:CME traded up $0.47 during trading hours on Thursday, hitting $176.50. 1,734,102 shares of the stock were exchanged, compared to its average volume of 1,566,127. CME Group has a 52-week low of $132.33 and a 52-week high of $182.97. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.15. The firm has a market cap of $57.79 billion, a P/E ratio of 37.00, a price-to-earnings-growth ratio of 3.20 and a beta of 0.64.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, July 26th. The financial services provider reported $1.74 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.72 by $0.02. CME Group had a return on equity of 9.03% and a net margin of 111.45%. The company had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same period in the previous year, the business earned $1.22 EPS. CME Group’s quarterly revenue was up 14.6% on a year-over-year basis. On average, research analysts forecast that CME Group will post 6.64 earnings per share for the current year.

In related news, President Bryan T. Durkin sold 11,509 shares of the company’s stock in a transaction that occurred on Monday, August 6th. The stock was sold at an average price of $162.01, for a total value of $1,864,573.09. Following the transaction, the president now directly owns 64,862 shares in the company, valued at $10,508,292.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jeffrey M. Bernacchi sold 4,976 shares of the company’s stock in a transaction that occurred on Tuesday, September 4th. The shares were sold at an average price of $176.60, for a total value of $878,761.60. Following the completion of the transaction, the director now owns 52,004 shares in the company, valued at $9,183,906.40. The disclosure for this sale can be found here. Insiders sold 26,688 shares of company stock worth $4,523,957 over the last quarter. 0.43% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Oak Ridge Investments LLC increased its position in shares of CME Group by 6.2% during the second quarter. Oak Ridge Investments LLC now owns 5,247 shares of the financial services provider’s stock worth $860,000 after acquiring an additional 306 shares during the period. Girard Partners LTD. increased its position in shares of CME Group by 10.3% during the second quarter. Girard Partners LTD. now owns 3,492 shares of the financial services provider’s stock worth $572,000 after acquiring an additional 326 shares during the period. Trust Co. of Vermont increased its position in shares of CME Group by 0.8% during the second quarter. Trust Co. of Vermont now owns 43,772 shares of the financial services provider’s stock worth $7,175,000 after acquiring an additional 327 shares during the period. Front Row Advisors LLC increased its position in shares of CME Group by 3.9% during the second quarter. Front Row Advisors LLC now owns 8,882 shares of the financial services provider’s stock worth $1,506,000 after acquiring an additional 335 shares during the period. Finally, MayTech Global Investments LLC increased its position in shares of CME Group by 0.7% during the second quarter. MayTech Global Investments LLC now owns 50,090 shares of the financial services provider’s stock worth $8,211,000 after acquiring an additional 338 shares during the period. Hedge funds and other institutional investors own 84.03% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Story: Dow Jones Industrial Average (DJIA)

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply